AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...
Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...
BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...
This $2.5 billion investment reflects AstraZeneca's belief in "the world-class life sciences ecosystem in Beijing" and its ...
AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...
AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...
AstraZeneca (AZN) announced an investment of $2.5B in Beijing to establish its sixth global strategic R&D center together with major ...
The deal includes the Belgian biotech’s in-vivo cell-therapy platform, which modifies immune cells within the patient’s body, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback